News

A study comparing pain perception during cataract surgery with and without the use of lidocaine.

A recent survey looked at how doctors adopt and use new technology, including the internet and found that overall an increasing amount of their time is being spent online and access to the most up-to-date online medical and pharmaceutical resources plays and increasingly important role.

A news round-up, including highlights from this year's ASCRS.

From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecendented rate. Communities of users interact globally, minute-to-minute within huge databases of content that they themselves create.

A comparative study of three presbyopia-correcting lenses demonstrates that aspheric lenses offer superior performance over other designs.

Technolas Perfect Vision is the new company name for the joint venture between Bausch & Lomb and 20/10 Perfect Vision AG that will focus on laser vision correction.

An angiostatic cortisene, Anercortave Acetate (AA), may prove to be the first treatment modality for open-angle glaucoma, which only needs to be administered every three months.

A look at how to introduce canaloplasty into your surgery; experience from two doctors.

Foveal thickness and macular volume decrease after phaco in eyes with diabetic macular oedema, with changes even more pronounced in patients with diabetic retinopathy.

Assessing whether certain surgical methods can minimize exposing the eye to oxidation during phacoemulsification/

Looking at an activity socring system to define lesions associated with wet AMD by quantifying their activity to determine the need for treatment.

Looking at a new technique to prepare and transplant endothelial grafts usinf subendothelial air injections to separate donor Descemet and endothelium from overlying stroma.

A common problem associated with cataract surgery is deviation from target refraction. This study examines whether variable IOL diameter can result in improvements.

Device holds promise for release of corticosteroids at varying doses.

The training component of the Mercy Vision programme, onboard the world's largest non-governmental hospital ship, is to receive $50,000 from the Alcon Foundation.

When injecting silicone oils with a viscosity of 5000 mPas, which are used frequently, retinal surgeons often reach limits of applicability.

“As we move into the 21st century the role of the IOL will evolve allowing better outcomes in cataract surgery and find new roles in surgery to improve vision such as through the treatment of presbyopia.”

New guidelines, designed to improve the management and diagnosis of chronic open angle glaucoma (COAG) and ocular hypertension have received a cautious commendation from the ophthalmic community.

Ultralase has become the first and only national provider to have all its UK surgeons accredited by the Royal College of Ophthalmologists (RCOphth).

The pioneering stem cell therapy, developed by British researchers to tackle AMD, has received the financial backing of pharma giant, Pfizer Inc., which is expected to pump in £50 million over the next three to five years.

You're an ophthalmologist? You use social media? Will Twitter change the way doctors practice medicine?

Is there a difference in intraocular scatter in eyes with mono and mulifocal IOLs?

Six doctors are the recipients of the Alcon Research Institute (ARI) awards for their outstanding research contributions in the field of ophthalmology and vision science.

We look into whether pIOLs stay in position after implantation in the long term, preventing damage to intraocular tissues and retain a good quality of vision.

The Visante omni is the first system to combine OCT and Placido disk technologies, providing comprehensive anterior and posterior topography for improved patient selection and care.

From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecedented rate. Communities of users interact globally, minute-to-minute within huge databases of content that they themselves create.

A worldwide licensing agreement for tafluprost, preserved and preservative-free formulations, has been announced between Merck & Co Inc., and Santen Pharmaceutical Co Ltd.

Interim analysis of Phase II trials for fenretinide and its use in the treatment of geographic atrophy (GA) are looking positive, according to Sirion Therapeutics, Inc.

Significant improvement in signs and symptoms in patients suffering from moderate-to-severe dry eye syndrome have been found following the Phase II trial of Cyclokat, the formulation of cyclosporine by French pharmaceutical ophthalmic company Novagali Pharma.

The side effects of an experimental 'gene-silencing' treatment that is currently being investigated for a variety of diseases could be useful in corneal transplantation, where growth of new blood and lymph vessels is believed to be a major cause of graft failure.